INPEN MMT-105NNPKNA NOVO NORDISK PINK
Report
- Report Number
- 3012822846-2021-00770
- Event Type
- Injury
- Date Received
- October 4, 2021
- Date of Event
- September 24, 2021
- Report Date
- January 13, 2022
- Manufacturer
- COMPANION MEDICAL INC
- Product Code
- FMF
- UDI-DI
- 000010862088000368
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NH, US
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
SERIAL NUMBER: (B)(6). SOFTWARE VERSION: 3.8.5. COLOR: PINK. BATTERY LIFE REMAINING: 5 MONTHS. CUSTOMER REPORTS: HIGH BG'S AND LEADSCREW ANOMALY. PER VISUAL INSPECTION: NO COSMETIC DAMAGE NOTED. THE FOLLOWING TEST VALUES WERE DIALED AND DOSED: 4.0U X 10 TIMES. ALL VALUES DISPLAYED ACCURATELY IN THE LOGBOOK AND WITHOUT DELAY. INPEN RECEIVED WITH LEADSCREW HALFWAY OF THE TRAVEL. RE-WOUND SCREW. NO DRAG WAS OBSERVED, THE SCREW WAS NOT BENT, ADVANCED WHEN DOSAGE KNOB WAS PRESSED DIALING A DOSAGE AND RETRACTED APPROPRIATELY. NO RESISTANCE WAS OBSERVED WHEN DOSING WITHOUT A CARTRIDGE INSTALLED. THE SCREW ADVANCED EVERY TIME 30.0U WAS DIALED AND DOSED UNTIL THE SCREW REACHED MAX EXTENSION. IN CONCLUSION: INPEN RECEIVED WORKING AS DESIGN. NO MALFUNCTIONS NOTED DURING TESTING THAT COULD AFFECT INSULIN DELIVERY. THE PATIENT COMPLAINT OF LEADSCREW ANOMALIES COULD NOT BE CONFIRMED. MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY "DEFECTS" OR HAS "MALFUNCTIONED". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT.
CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME.
CUSTOMER REPORTED VIA PHONE CALL THAT THEY WERE EXPERIENCED HIGH BLOOD GLUCOSE. THE BLOOD GLUCOSE WAS 400+ MG/DL AT THE TIME OF INCIDENT. CUSTOMER STATED THAT THE INPEN USUALLY DOES A SMALL SQUIRT WHEN PRIMES IT AND ONE DID VERY LITTLE INSULIN AND SO DID THE 2ND CARTRIDGE. THE INPEN WILL BE RETURNED FOR ANALYSIS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1465878 | INPEN MMT-105NNPKNA NOVO NORDISK PINK | SYRINGE, PISTON | FMF | COMPANION MEDICAL INC | MMT-105NNPKNA | B94JJ | 000010862088000368 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 6 YR | Unknown | Other |